Sign In

Use the Qualified Clinical Data Registry (QCDR) to complete Merit-Based Incentive Payment System reporting.

Report on evidence-based quality measures and receive performance scores via the Quality Oncology Practice Initiative (QOPI®).

Oncology Practice Insider

ASCO’s Oncology Practice Insider provides the latest news, information, and educational tools to assist with the successful management of oncology practice and the delivery of high quality patient care. OPI offers updates on ASCO programs, services, and cancer-related health policy, Medicare news, and billing and coding best practices. To sign up for the biweekly Oncology Practice Insider newsletter, please complete this form.

ASCO submitted comments to the Centers for Medicare & Medicaid Services (CMS) in response to a proposed rule regarding Secure Electronic Prior Authorization for Medicare Part D. Under the proposal, clinicians would be able to complete prior authorizations for Part D prescriptions online and through a more streamlined process.
On August 2, the Centers for Medicare and Medicaid (CMS) released the Hospital Inpatient Prospective Payment System final rule for fiscal year 2020. The rule finalizes changes that will affect all U.S. hospitals, including:
ASCO membership empowers you to be part of a larger voice advocating on behalf of the oncology profession to ensure that the real challenges facing oncology practices are taken into consideration by policymakers. You can get involved with the ASCO ACT Network and stay up-to-date with ASCO in Action on emerging government policies, regulations, and legal issues that may impact the practice of oncology. Learn more about the value of ASCO membership and gain what you need.
ASCO, CancerLinQ LLC and its technology collaborator Concerto HealthAI, and data from CancerLinQ® participating practices will be part of the upcoming “8th Annual Blueprint for Breakthrough Forum—Validating Real-World Endpoints for an Evolving Regulatory Landscape” forum hosted by Friends of Cancer Research. The September 18 event will be held at The Ritz Carlton in Washington, D.C.
In the latest ASCO in Action Podcast, Lisa Lacasse, President of the American Cancer Society Cancer Action Network (ACS CAN), joins Dr. Hudis to discuss the critical importance of advocacy and ACS CAN’s partnership with ASCO in reducing the cancer burden.
The Georgia Society of Clinical Oncology successfully worked to move two important PBM bills through the Georgia legislature. Read more about their advocacy efforts and how you can work with your state society to affect policy on behalf of your patients and practices. “We felt that if we were able to get this legislature to pass bill, then other states would be able to use it as a model,” Dr. Melissa Dillmon said. Read more in the ASCO Daily News.
The American Society of Clinical Oncology (ASCO) recently received clarification from the United States Pharmacopeia (USP) around the newly revised USP General Chapter <797> Pharmaceutical Compounding Standards – Sterile Preparations and USP General Chapter <800> Hazardous Drugs – Handling in Healthcare Settings, which become official December 1, 2019 and may not apply to most U.S. oncology practices that administer and prepare oncological agents.
Fourteen out of 16 members of the House GOP Doctors Caucus sent a letter in early July to HHS Secretary Alex Azar and CMS Administrator Seema Verma requesting that they reconsider the step therapy policy that